Mattias Höglund
11 – 20 of 161
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
A comparison of rule-based and centroid single-sample multiclass predictors for transcriptomic classification
(
- Contribution to journal › Article
-
Mark
Reply to Joep J. de Jong and Ewan A. Gibb's Letter to the Editor re: Gottfrid Sjödahl, Johan Abrahamsson, Karin Holmsten, et al. Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes. Eur Urol. 2022;81:316-7. Neoadjuvant Chemotherapy Response in Muscle-invasive Bladder Cancer: Differences in Intrinsic Biology or Subtyping Nomenclature?
(
- Contribution to journal › Letter
-
Mark
Molecular pathology of the non-luminal Ba/Sq-like and Sc/NE-like classes of urothelial tumours : An integrated immunohistochemical analysis
(
- Contribution to journal › Article
-
Mark
Patient-Derived Bladder Cancer Organoid Models in Tumor Biology and Drug Testing : A Systematic Review
(
- Contribution to journal › Scientific review
- 2021
-
Mark
When the Molecular Subtype Is Hidden Behind a Veil of Stroma
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
(
- Contribution to journal › Article
-
Mark
Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight
(
- Contribution to journal › Article
- 2020
-
Mark
Analysis of fusion transcripts indicates widespread deregulation of snoRNAs and their host genes in breast cancer
(
- Contribution to journal › Article
-
Mark
Molecular changes during progression from nonmuscle invasive to advanced urothelial carcinoma
(
- Contribution to journal › Article
-
Mark
A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
(
- Contribution to journal › Article